Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Juno Therapeutics Inc. buy melinda

Juno Therapeutics Inc.
Start price
€48.38
06.12.17 / 50%
Target price
€55.92
20.12.17
Performance (%)
-17.88%
End price
€39.73
20.12.17
Summary
This prediction ended on 20.12.17 with a price of €39.73. The prediction for Juno Therapeutics Inc. disappointed with a performance of -17.88%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Juno Therapeutics Inc. - - - -
iShares Core DAX® -0.874% 5.325% 6.865% 65.211%
iShares Nasdaq 100 -0.381% 1.979% 25.696% 90.325%
iShares Nikkei 225® -1.676% 1.952% 41.443% 80.623%
iShares S&P 500 -0.655% 2.069% 21.405% 70.737%

Comments by melinda for this prediction

In the thread Juno Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -17.88%
Target price 55.924
Change
Ends at 20.12.17

2017.11.12 Die aktualisierten Daten aus Phase 1 werden 11, bei ASH Dezember 2017 vorgelegt werden.



JCAR017
r / r Non-Hodgkin-B-Zell - Lymphom - Krebs
Phase 1/2



melinda 
0
Report Share
06.12.17
Prediction Buy
Perf. (%) -17.88%
Target price 55.924
Change
Ends at 20.12.17

(Vom Mitglied beendet)

melinda 
0
Report Share
20.12.17

Stopped prediction by melinda for Juno Therapeutics Inc.

buy
Juno Therapeutics Inc.

Start price
Target price
Perf. (%)
€43.69
05.01.18
€56.38
17.01.18
39.54%
17.01.18

melinda 
18.08.19 50%
buy
Juno Therapeutics Inc.

Start price
Target price
Perf. (%)
€27.85
14.07.16
€44.20
16.01.17
-35.22%
16.01.17

melinda 
14.08.19 50%